Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139

Functional organization of the yeast proteome by systematic analysis of protein complexes

Gavin, A.-C., Bösche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A.-M., Cruciat, C.-M., et al. (2002) · Nature · doi:10.1038/415141a · Cited by 4,759

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305

Towards a proteome-scale map of the human protein–protein interaction network

Rual, J.-F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,933

Nitric oxide synthases: Roles, tolls, and controls

Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918

Principles of protein-protein interactions

Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684

Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery

Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568

HSP90 and the chaperoning of cancer

Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502

A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome

Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F. H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.029 · Cited by 2,387

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206

A Hot Spot of Binding Energy in a Hormone-Receptor Interface

Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983

Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960

Interactome Networks and Human Disease

Vidal, M., Cusick, M. E., & Barabási, A.-L. (2011) · Cell · doi:10.1016/j.cell.2011.02.016 · Cited by 1,771

The HSP70 chaperone machinery: J proteins as drivers of functional specificity

Kampinga, H. H., & Craig, E. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2941 · Cited by 1,755

The Amyloid State of Proteins in Human Diseases

Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744

Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476

Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349

Structure of TPR Domain–Peptide Complexes

Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Hartl, F. U., & Moarefi, I. (2000) · Cell · doi:10.1016/s0092-8674(00)80830-2 · Cited by 1,188

Converging concepts of protein folding in vitro and in vivo

Hartl, F. U., & Hayer-Hartl, M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1591 · Cited by 1,185

HIV-1: Fifteen Proteins and an RNA

Frankel, A. D., & Young, J. A. T. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.1 · Cited by 920

Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information

Good, M. C., Zalatan, J. G., & Lim, W. A. (2011) · Science · doi:10.1126/science.1198701 · Cited by 885

Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon

Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 884

Synthetic Multivalent Ligands as Probes of Signal Transduction

Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864

Annual Review of Cell and Developmental Biology 2001

Telser, A. (2002) · Shock · doi:10.1097/00024382-200209000-00016 · Cited by 846

The structural basis of the activation of Ras by Sos

Boriack-Sjodin, P. A., Margarit, S. M., Bar-Sagi, D., & Kuriyan, J. (1998) · Nature · doi:10.1038/28548 · Cited by 799

The rise of fragment-based drug discovery

Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 791

Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis

Tesmer, J. J. G., Berman, D. M., Gilman, A. G., & Sprang, S. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80204-4 · Cited by 779

Mechanism of XIAP-Mediated Inhibition of Caspase-9

Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., & Shi, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00054-6 · Cited by 719

Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?

Keskin, O., Gursoy, A., Ma, B., & Nussinov, R. (2008) · Chemical Reviews · doi:10.1021/cr040409x · Cited by 697

Structure-based maximal affinity model predicts small-molecule druggability

Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695

Convergent Solutions to Binding at a Protein-Protein Interface

DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708917105 · Cited by 660

Structure-based design of potent non-peptide MDM2 inhibitors

Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., Krajewski, K., Roller, P. P., Tomita, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051147z · Cited by 657

Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653

Small-Molecule Inhibition of TNF-α

He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620

Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

Maurer, T., Garrenton, L. S., Oh, A., Pitts, K., Anderson, D. J., Skelton, N. J., Fauber, B. P., Pan, B., Malek, S., Stokoe, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116510109 · Cited by 618

A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein−Protein Interaction

Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600

Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition

von Kleist, L., Stahlschmidt, W., Bulut, H., Gromova, K., Puchkov, D., Robertson, M. J., MacGregor, K. A., Tomilin, N., Pechstein, A., Chau, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.025 · Cited by 573

Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G

Moerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 572

X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA

Nair, S. K., & Burley, S. K. (2003) · Cell · doi:10.1016/s0092-8674(02)01284-9 · Cited by 551

The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones

Li, J., Soroka, J., & Buchner, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.09.003 · Cited by 498

Crystal Structure of the Nucleotide Exchange Factor GrpE Bound to the ATPase Domain of the Molecular Chaperone DnaK

Harrison, C. J., Hayer-Hartl, M., Liberto, M. D., Hartl, F.-U., & Kuriyan, J. (1997) · Science · doi:10.1126/science.276.5311.431 · Cited by 497

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M. L., Seehra, J., Somers, W. S., & Mosyak, L. (2001) · Nature · doi:10.1038/35069118 · Cited by 489

Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication

Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Grembecka, J., He, S., Shi, A., Purohit, T., Muntean, A. G., Sorenson, R. J., Showalter, H. D., Murai, M. J., Belcher, A. M., Hartley, T., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.773 · Cited by 462

A Small Molecule Inhibitor of Inducible Heat Shock Protein 70

Leu, J. I.-J., Pimkina, J., Frank, A., Murphy, M. E., & George, D. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.023 · Cited by 441

Detecting Protein−Protein Interactions with a Green Fluorescent Protein Fragment Reassembly Trap: Scope and Mechanism

Magliery, T. J., Wilson, C. G. M., Pan, W., Mishler, D., Ghosh, I., Hamilton, A. D., & Regan, L. (2005) · Journal of the American Chemical Society · doi:10.1021/ja046699g · Cited by 441

Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target

Evans, C. G., Chang, L., & Gestwicki, J. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100054f · Cited by 436

Stapled Peptides for Intracellular Drug Targets

Verdine, G. L., & Hilinski, G. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00001-x · Cited by 433

Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells

Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432

Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75

Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408

Crystal Structure of a β-Catenin/Tcf Complex

Graham, T. A., Weaver, C., Mao, F., Kimelman, D., & Xu, W. (2000) · Cell · doi:10.1016/s0092-8674(00)00192-6 · Cited by 405

Tethering: Fragment-Based Drug Discovery

Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385

The origin of protein interactions and allostery in colocalization

Kuriyan, J., & Eisenberg, D. (2007) · Nature · doi:10.1038/nature06524 · Cited by 383

Protein–protein interactions in human disease

RYAN, D., & MATTHEWS, J. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.06.001 · Cited by 375

Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer

Oost, T. K., Sun, C., Armstrong, R. C., Al-Assaad, A.-S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040037k · Cited by 366

Hot Spots for Allosteric Regulation on Protein Surfaces

Reynolds, K. A., McLaughlin, R. N., & Ranganathan, R. (2011) · Cell · doi:10.1016/j.cell.2011.10.049 · Cited by 356

Covalent Modifiers: An Orthogonal Approach to Drug Design

Potashman, M. H., & Duggan, M. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8008597 · Cited by 346

From the cradle to the grave: molecular chaperones that may choose between folding and degradation

Höhfeld, J., Cyr, D. M., & Patterson, C. (2001) · EMBO reports · doi:10.1093/embo-reports/kve206 · Cited by 338

Inhibitors of the heat shock response: Biology and pharmacology

Powers, M. V., & Workman, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.040 · Cited by 320

Integrating molecular and network biology to decode endocytosis

Schmid, E. M., & McMahon, H. T. (2007) · Nature · doi:10.1038/nature06031 · Cited by 315

Structure of the negative regulatory domain of p53 bound to S100B(betabeta).

Weber, D. J., Rust, R. R., & Baldisseri, D. M. (2000) · Nature Structural Biology · doi:10.1038/76797 · Cited by 314

Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket

Donnelly, A., & Blagg, B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242895 · Cited by 313

Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless

Sondermann, H., Soisson, S. M., Boykevisch, S., Yang, S.-S., Bar-Sagi, D., & Kuriyan, J. (2004) · Cell · doi:10.1016/j.cell.2004.10.005 · Cited by 311

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Bruncko, M., Oost, T. K., Belli, B. A., Ding, H., Joseph, M. K., Kunzer, A., Martineau, D., McClellan, W. J., Mitten, M., Ng, S.-C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061152t · Cited by 304

An orthosteric inhibitor of the Ras-Sos interaction

Patgiri, A., Yadav, K. K., Arora, P. S., & Bar-Sagi, D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.612 · Cited by 295

Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins

Wang, G., Nikolovska-Coleska, Z., Yang, C.-Y., Wang, R., Tang, G., Guo, J., Shangary, S., Qiu, S., Gao, W., Yang, D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060460o · Cited by 292

Modulation of Protein–Protein Interactions with Small Organic Molecules

Berg, T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200558 · Cited by 292

Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery

Meyer, P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600141 · Cited by 291

Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress

Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281

Therapeutic and diagnostic implications of Hsp90 activation

Kamal, A., Boehm, M. F., & Burrows, F. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.006 · Cited by 278

The bacterial cell-division protein ZipA and its interaction with an FtsZ fragment revealed by X-ray crystallography

Mosyak, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3179 · Cited by 276

Regulation of Hsp90 ATPase Activity by the Co-chaperone Cdc37p/p50

Siligardi, G., Panaretou, B., Meyer, P., Singh, S., Woolfson, D. N., Piper, P. W., Pearl, L. H., & Prodromou, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201287200 · Cited by 272

Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

Bagatell, R., Paine-Murrieta, G. D., Taylor, C. W., Pulcini, E. J., Akinaga, S., Benjamin, I. J., & Whitesell, L. J. (2000) · PubMed · Cited by 269

Recognizing molecules with drug-like properties

Walters, W. P., Murcko, A. A., & Murcko, M. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80058-1 · Cited by 266

Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly

Braisted, A. C., Oslob, J. D., Delano, W. L., Hyde, J., McDowell, R. S., Waal, N., Yu, C., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256

The modular architecture of protein–protein binding interfaces

Reichmann, D., Rahat, O., Albeck, S., Meged, R., Dym, O., & Schreiber, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407280102 · Cited by 239

Life of a clathrin coat: insights from clathrin and AP structures

Edeling, M. A., Smith, C., & Owen, D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1786 · Cited by 238

The architecture of functional modules in the Hsp90 co‐chaperone Sti1/Hop

Schmid, A. B., Lagleder, S., Gräwert, M. A., Röhl, A., Hagn, F., Wandinger, S. K., Cox, M. B., Demmer, O., Richter, K., Groll, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.472 · Cited by 229

Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)

Morelli, X., Bourgeas, R., & Roche, P. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.024 · Cited by 223

Solution of the Structure of the TNF-TNFR2 Complex

Mukai, Y., Nakamura, T., Yoshikawa, M., Yoshioka, Y., Tsunoda, S.-I., Nakagawa, S., Yamagata, Y., & Tsutsumi, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2000954 · Cited by 221

The role of nitric oxide in articular cartilage breakdown in osteoarthritis

Amin, A. R., & Abramson, S. B. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199805000-00018 · Cited by 217

Structural Basis of J Cochaperone Binding and Regulation of Hsp70

Jiang, J., Maes, E. G., Taylor, A. B., Wang, L., Hinck, A. P., Lafer, E. M., & Sousa, R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.022 · Cited by 215

A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor

Zhang, H., Zhao, Q., Bhattacharya, S., Waheed, A. A., Tong, X., Hong, A., Heck, S., Curreli, F., Goger, M., Cowburn, D., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.066 · Cited by 215

The Structure of Interleukin-2 Complexed with Its Alpha Receptor

Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1109745 · Cited by 212

Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle

Siligardi, G., Hu, B., Panaretou, B., Piper, P. W., Pearl, L. H., & Prodromou, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410562200 · Cited by 207

Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides

Dutia, B. M., Frame, M. C., Subak-Sharpe, J. H., Clark, W. N., & Marsden, H. S. (1986) · Nature · doi:10.1038/321439a0 · Cited by 202

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 201

Hsp70 Molecular Chaperones: Emerging Roles in Human Disease and Identification of Small Molecule Modulators

Brodsky, J., & Chiosis, G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777811997 · Cited by 200

Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation

Gestwicki, J. E., Crabtree, G. R., & Graef, I. A. (2004) · Science · doi:10.1126/science.1101262 · Cited by 200

Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction

Zhang, T., Li, Y., Yu, Y., Zou, P., Jiang, Y., & Sun, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051532 · Cited by 199

Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors

Jochim, A. L., & Arora, P. S. (2010) · ACS Chemical Biology · doi:10.1021/cb1001747 · Cited by 191

The road less traveled: modulating signal transduction enzymes by inhibiting their protein–protein interactions

Arkin, M. R., & Whitty, A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.05.125 · Cited by 190

Structural biology and drug discovery for protein–protein interactions

Jubb, H., Higueruelo, A. P., Winter, A., & Blundell, T. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.006 · Cited by 181

Chromatin Regulatory Mechanisms in Pluripotency

Lessard, J. A., & Crabtree, G. R. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-051809-102012 · Cited by 181

Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90–Cdc37, a Kinome Chaperone–Cochaperone, by Triterpene Celastrol

Sreeramulu, S., Gande, S. L., Göbel, M., & Schwalbe, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900929 · Cited by 178

Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy

Porter, J. R., Fritz, C. C., & Depew, K. M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.019 · Cited by 177

Protein–protein interactions and cancer: small molecules going in for the kill

Arkin, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.03.001 · Cited by 175

Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization

Findeis, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00034-x · Cited by 174

Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2

Cohen, E. A., Gaudreau, P., Brazeau, P., & Langelier, Y. (1986) · Nature · doi:10.1038/321441a0 · Cited by 173

Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor

Fernandez-Fernandez, M. R., Veprintsev, D. B., & Fersht, A. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501459102 · Cited by 171

Insight into Amyloid Structure Using Chemical Probes

Reinke, A. A., & Gestwicki, J. E. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01110.x · Cited by 169

Atomic Interactions and Profile of Small Molecules Disrupting Protein–Protein Interfaces: the TIMBAL Database

Higueruelo, A. P., Schreyer, A. M., Bickerton, G. R., Pitt, W. R., Groom, C. R., & Blundell, T. L. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00889.x · Cited by 166

Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery

Meyer, P., Prodromou, C., Liao, C., Hu, B., Mark Roe, S., Vaughan, C. K., Vlasic, I., Panaretou, B., Piper, P. W., & Pearl, L. H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600060 · Cited by 166

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.

Balzarini, J., Pérez-Pérez, M. J., San-Félix, A., Schols, D., Perno, C. F., Vandamme, A. M., Camarasa, M. J., & De Clercq, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4392 · Cited by 162

The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2

Abbate, E. A., Berger, J. M., & Botchan, M. R. (2004) · Genes & Development · doi:10.1101/gad.1220104 · Cited by 160

Binding of a Small Molecule at a Protein–Protein Interface Regulates the Chaperone Activity of Hsp70–Hsp40

Wisén, S., Bertelsen, E. B., Thompson, A. D., Patury, S., Ung, P., Chang, L., Evans, C. G., Walter, G. M., Wipf, P., Carlson, H. A., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb1000422 · Cited by 160

Selective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules

Kiessling, A., Sperl, B., Hollis, A., Eick, D., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.011 · Cited by 153

Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide

Zhang, Z., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L., & Kézdy, F. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98445-0 · Cited by 150

Trapping Moving Targets with Small Molecules

Lee, G., & Craik, C. S. (2009) · Science · doi:10.1126/science.1169378 · Cited by 147

High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK

Chang, L., Bertelsen, E. B., Wisén, S., Larsen, E. M., Zuiderweg, E. R. P., & Gestwicki, J. E. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.08.020 · Cited by 147

Hot-spot mimicry of a cytokine receptor by a small molecule

Thanos, C. D., DeLano, W. L., & Wells, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607058103 · Cited by 144

The central region of HDM2 provides a second binding site for p53

Yu, G. W., Rüdiger, S., Veprintsev, D. B., Freund, S. M. V., Fernández-Fernández, M. R., & Fersht, A. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510343103 · Cited by 139

Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay

Roman, D. L., Talbot, J. N., Roof, R. A., Sunahara, R. K., Traynor, J. R., & Neubig, R. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028670 · Cited by 137

Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP

Vucic, D., Franklin, M. C., Wallweber, H. J. A., Kanad, D. A. S., Eckelman, B. P., Shin, H., Elliott, L. O., Kadkhodayan, S., Deshayes, K., Salvesen, G. S., et al. (2004) · Biochemical Journal · doi:10.1042/bj20041108 · Cited by 136

Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and III

Panda, K., Rosenfeld, R. J., Ghosh, S., Meade, A. L., Getzoff, E. D., & Stuehr, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203749200 · Cited by 135

From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery

Meimaridou, E., Gooljar, S. B., & Chapple, J. P. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0116 · Cited by 135

Enhancements of screening collections to address areas of unmet medical need: an industry perspective

Drewry, D. H., & Macarrón, R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.024 · Cited by 134

Pharmacological Targeting of the Hsp70 Chaperone

Patury, S., Miyata, Y., & Gestwicki, J. E. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895674 · Cited by 131

Heat shock protein 70 kDa chaperone/DnaJ cochaperone complex employs an unusual dynamic interface

Ahmad, A., Bhattacharya, A., McDonald, R. A., Cordes, M., Ellington, B., Bertelsen, E. B., & Zuiderweg, E. R. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111220108 · Cited by 130

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129

Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database

Bourgeas, R., Basse, M.-J., Morelli, X., & Roche, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009598 · Cited by 126

Intrinsically disordered proteins and novel strategies for drug discovery

Uversky, V. N. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.686489 · Cited by 121

Allosteric Inhibition of the Protein-Protein Interaction between the Leukemia-Associated Proteins Runx1 and CBFβ

Gorczynski, M. J., Grembecka, J. E., Zhou, Y., Kong, Y., Roudaia, L., Douvas, M. G., Newman, M. N., Bielnicka, I., Baber, G. B., Corpora, T., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.09.006 · Cited by 116

A Novel Class of Small Molecule Inhibitors of Hsp90

Yi, F., & Regan, L. (2008) · ACS Chemical Biology · doi:10.1021/cb800162x · Cited by 116

Two distinct interaction motifs in amphiphysin bind two independent sites on the clathrin terminal domain β-propeller

Miele, A. E., Watson, P. J., Evans, P. R., Traub, L. M., & Owen, D. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb736 · Cited by 116

A systematic method for identifying small-molecule modulators of protein–protein interactions

Horswill, A. R., Savinov, S. N., & Benkovic, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406999101 · Cited by 110

Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery

Valkov, E., Sharpe, T., Marsh, M., Greive, S., & Hyvönen, M. (2011) · Topics in Current Chemistry · doi:10.1007/128_2011_265 · Cited by 107

Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc11Edited by P. E. Wright

Fieber, W., Schneider, M. L., Dunzendorfer-Matt, T., Kräutler, B., Konrat, R., & Bister, K. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4537 · Cited by 107

A synergistic small-molecule combination directly eradicates diverse prion strain structures

Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N., & Shorter, J. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.246 · Cited by 107

Agonism/antagonism switching in allosteric ensembles

Motlagh, H. N., & Hilser, V. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120519109 · Cited by 106

Protein–protein interactions: mechanisms and modification by drugs

Veselovsky, A. V., Ivanov, Y. D., Ivanov, A. S., Archakov, A. I., Lewi, P. J., & Janssen, P. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.597 · Cited by 105

Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases.

Weber, I. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86974-5 · Cited by 104

Structural identification of the pathway of long-range communication in an allosteric enzyme

Gandhi, P. S., Chen, Z., Mathews, F. S., & Di, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710894105 · Cited by 103

Chemical Screens against a Reconstituted Multiprotein Complex: Myricetin Blocks DnaJ Regulation of DnaK through an Allosteric Mechanism

Chang, L., Miyata, Y., Ung, P. M. U., Bertelsen, E. B., McQuade, T. J., Carlson, H. A., Zuiderweg, E. R. P., & Gestwicki, J. E. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.12.010 · Cited by 101

Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor

Wang, Y., Coulombe, R., Cameron, D. R., Thauvette, L., Massariol, M.-J., Amon, L. M., Fink, D., Titolo, S., Welchner, E., Yoakim, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311376200 · Cited by 98

Natural product-like chemical space: search for chemical dissectors of macromolecular interactions

Reayi, A., & Arya, P. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.007 · Cited by 95

A credit-card library approach for disrupting protein–protein interactions

Xu, Y., Shi, J., Yamamoto, N., Moss, J. A., Vogt, P. K., & Janda, K. D. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.052 · Cited by 93

Identification and Characterization of Small Molecule Inhibitors of the Calcium-Dependent S100B−p53 Tumor Suppressor Interaction

Markowitz, J., Chen, I., Gitti, R. K., Baldisseri, D. M., Pan, Y., Udan, R. S., Carrier, F., MacKerell, A. D., & Weber, D. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497038 · Cited by 91

Design and Validation of a Neutral Protein Scaffold for the Presentation of Peptide Aptamers

Woodman, R., Yeh, J. T. ‐., Laurenson, S. X., & Ferrigno, P. K. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.001 · Cited by 90

Miniature Protein Inhibitors of the p53–hDM2 Interaction

Kritzer, J. A., Zutshi, R., Cheah, M. T., Ran, F. A., Webman, R. B., Wongjirad, T. M., & Schepartz, A. (2006) · ChemBioChem · doi:10.1002/cbic.200500324 · Cited by 90

Structure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction

Wang, T., Han, X., Yan, M., Xu, Y., Duggineni, S., Lin, N., Luo, G., Li, Y. M., Han, X., Huang, Z., et al. (2011) · Biochemistry · doi:10.1021/bi201428h · Cited by 88

Characterization and prediction of protein–protein interactions within and between complexes

Sprinzak, E., Altuvia, Y., & Margalit, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603352103 · Cited by 87

Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: An Approach for Inhibiting Protein−Protein Interactions

Raimundo, B. C., Oslob, J. D., Braisted, A. C., Hyde, J., McDowell, R. S., Randal, M., Waal, N. D., Wilkinson, J., Yu, C. H., & Arkin, M. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049967u · Cited by 86

Amyloid binding ligands as Alzheimer’s disease therapies

Lee, V. M. ‐. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00121-5 · Cited by 81

Context-Based Identification of Protein-Protein Interfaces and “Hot-Spot” Residues

Geppert, T., Hoy, B., Wessler, S., & Schneider, G. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.01.005 · Cited by 80

A General and Rapid Cell-Free Approach for the Interrogation of Protein−Protein, Protein−DNA, and Protein−RNA Interactions and their Antagonists Utilizing Split-Protein Reporters

Porter, J. R., Stains, C. I., Jester, B. W., & Ghosh, I. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7114579 · Cited by 78

Fragment-Based Drug Discovery and X-Ray Crystallography

Davies, T. G., & Hyvönen, M. (2012) · Topics in current chemistry · doi:10.1007/978-3-642-27540-1 · Cited by 77

NMR structure of a complex between MDM2 and a small molecule inhibitor

Fry, D. C., Emerson, S. D., Palme, S., Vu, B. T., Liu, C., & Podlaski, F. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000048856.84603.9b · Cited by 75

Modulating Protein–Protein Interactions with Small Molecules: The Importance of Binding Hotspots

Thangudu, R. R., Bryant, S. H., Panchenko, A. R., & Madej, T. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.026 · Cited by 71

Macrocycles That Inhibit the Binding between Heat Shock Protein 90 and TPR-Containing Proteins

Ardi, V. C., Alexander, L. D., Johnson, V. A., & McAlpine, S. R. (2011) · ACS Chemical Biology · doi:10.1021/cb200203m · Cited by 69

Discovery of Modulators of Protein-Protein Interactions: Current Approaches and Limitations

Meireles, L., & Mustata, G. I. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794072632 · Cited by 69

ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90

Massey, A. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100342z · Cited by 68

Thermodynamics of the high-affinity interaction of TCF4 with β-catenin

Knapp, S., Zamai, M., Volpi, D., Nardese, V., Avanzi, N. R., Breton, J., Plyte, S. E., Flocco, M. M., Marconi, M., Isacchi, A., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4463 · Cited by 66

Molecular Chaperones and Regulation of Tau Quality Control: Strategies for Drug Discovery in Tauopathies

Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64

The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy

Sreeramulu, S., Jonker, H. R. A., Langer, T., Richter, C. P., Lancaster, C. R. D., & Schwalbe, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806715200 · Cited by 63

Amphipathic Small Molecules Mimic the Binding Mode and Function of Endogenous Transcription Factors

Buhrlage, S. J., Bates, C. A., Rowe, S. P., Minter, A. R., Brennan, B. B., Majmudar, C. Y., Wemmer, D. E., Al‐Hashimi, H. M., & Mapp, A. K. (2009) · ACS Chemical Biology · doi:10.1021/cb900028j · Cited by 63

Small Molecule Inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture Mechanism

Silvian, L. F., Friedman, J. E., Strauch, K., Cachero, T. G., Day, E. S., Qian, F., Cunningham, B. C., Fung, A. D., Sun, L., Su, L., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb2000346 · Cited by 57

Inhibition of HIV-1 Protease by a Subunit of Didemnaketal A

Fan, X., Flentke, G. R., & Rich, D. H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja981306x · Cited by 56

Label Transfer Chemistry for the Characterization of Protein−Protein Interactions

Liu, B., Archer, C. T., Burdine, L. J., Gillette, T. G., & Kodadek, T. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072904r · Cited by 55

Chemical Control Over Protein-Protein Interactions: Beyond Inhibitors

Gestwicki, J. E., & Marinec, P. S. (2007) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620707782507296 · Cited by 55

Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1

Erbe, D. V., Wang, S., Xing, Y., & Tobin, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110162200 · Cited by 52

Identification of a Small Molecule that Inhibits Herpes Simplex Virus DNA Polymerase Subunit Interactions and Viral Replication

Pilger, B., Cui, C., & Coen, D. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.01.018 · Cited by 51

High-Throughput Screen for Escherichia coli Heat Shock Protein 70 (Hsp70/DnaK): ATPase Assay in Low Volume by Exploiting Energy Transfer

Miyata, Y., Chang, L., Bainor, A. J., McQuade, T. J., Walczak, C. P., Zhang, Y., Larsen, M. J., Kirchhoff, P. D., & Gestwicki, J. E. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110380571 · Cited by 51

Cellular strategies for the assembly of molecular machines

Chari, A., & Fischer, U. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.006 · Cited by 50

Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases

Brandt, G. E. L., & Blagg, B. S. J. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895683 · Cited by 50

Assembly of b/HLH/z Proteins c-Myc, Max, and Mad1 with Cognate DNA: Importance of Protein−Protein and Protein−DNA Interactions

Hu, J., Banerjee, A., & Goss, D. J. (2005) · Biochemistry · doi:10.1021/bi050206i · Cited by 49

Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic Bcl-2 Proteins

Tang, G., Yang, C., Nikolovska‐Coleska, Z., Guo, J., Qiu, S., Wang, R., Gao, W., Wang, G., Stuckey, J. A., Krajewski, K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061400l · Cited by 48

Identifying Modulators of Protein−Protein Interactions Using Photonic Crystal Biosensors

Heeres, J. T., Kim, S.-H., Leslie, B. J., Lidstone, E. A., Cunningham, B. T., & Hergenrother, P. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907066r · Cited by 47

Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex

Tsiang, M., Jones, G. S., Hung, M., Mukund, S., Han, B., Liu, X., Babaoglu, K., Lansdon, E. B., Chen, X., Todd, J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040121 · Cited by 46

Characterization of the dimerization process of HIV‐1 reverse transcriptase heterodimer using intrinsic protein fluorescence

Divita, G., Restle, T., & Goody, R. S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81383-b · Cited by 42

Transcriptional Switches: Chemical Approaches to Gene Regulation

Lee, L. W., & Mapp, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.075044 · Cited by 41

Computational Analysis of Protein Hotspots

Yang, C., & Wang, S. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100026a · Cited by 32

Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy

Gordo, S., & Giralt, E. (2009) · Protein Science · doi:10.1002/pro.43 · Cited by 29

Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer

Ding, J., Jacobo‐Molina, A., Tantillo, C., Lu, X., Nanni, R. G., & Arnold, E. (1994) · Journal of Molecular Recognition · doi:10.1002/jmr.300070212 · Cited by 27

Improving the Antiviral Efficacy and Selectivity of HIV-1 Reverse Transcriptase Inhibitor TSAO-T by the Introduction of Functional Groups at the N-3 Position

Bonache, M.-C., Chamorro, C., Velázquez, S., Clercq, E. D., Balzarini, J. M., Rodríguez‐Barrios, F., Gago, F., Camarasa, M., & San‐Félix, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050437n · Cited by 24

‘Nature-inspired’ drug–protein complexes as inhibitors of Aβ aggregation

Bose, M., Gestwicki, J. E., Devasthali, V., Crabtree, G. R., & Graef, I. A. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330543 · Cited by 21

Application of mass spectrometry to study proteomics and interactomics in cystic fibrosis.

Balch, W., & Yates, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-120-8_14 · Cited by 13

Expanding the repertoire of small molecule transcriptional activation domains

Casey, R. J., Desaulniers, J., Højfeldt, J. W., & Mapp, A. K. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.045 · Cited by 12

Nucleating the Assembly of Macromolecular Complexes

Peterson‐Kaufman, K. J., Carlson, C. D., Rodríguez‐Martínez, J. A., & Ansari, A. Z. (2010) · ChemBioChem · doi:10.1002/cbic.201000255 · Cited by 8

Branched Peptides for the Modulation of Protein-Protein Interactions: More Arms are Better than One?

Ruvo, M., Sandomenico, A., Tudisco, L., & Falco, S. D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843191 · Cited by 7

The re-emergence of natural products for drug discovery in the genomics era

Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572

Therapeutic Peptides: Current Applications and Future Directions

Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality

Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891